424 related articles for article (PubMed ID: 27340145)
61. Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function.
Taylor A; Jones T; Forehand CC; Smith SE; Dykes H; Newsome AS
J Pharm Pract; 2022 Dec; 35(6):879-885. PubMed ID: 33977793
[TBL] [Abstract][Full Text] [Related]
62. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
[TBL] [Abstract][Full Text] [Related]
63. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?
Carr AC; Shaw GM; Fowler AA; Natarajan R
Crit Care; 2015 Nov; 19():418. PubMed ID: 26612352
[TBL] [Abstract][Full Text] [Related]
64. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
Bissell BD; Flannery AH
J Intensive Care Med; 2019 Jan; 34(1):79-80. PubMed ID: 30798672
[No Abstract] [Full Text] [Related]
65. Predictors of Vasopressin Responsiveness in Critically Ill Adults.
Allen B; Kram B; Kram S; Schultheis J; Wolf S; Gilstrap D; Shapiro M
Ann Pharmacother; 2018 Feb; 52(2):126-132. PubMed ID: 28853293
[TBL] [Abstract][Full Text] [Related]
66. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
Serpa Neto A; Nassar AP; Cardoso SO; Manetta JA; Pereira VG; Espósito DC; Damasceno MC; Russell JA
Crit Care; 2012 Aug; 16(4):R154. PubMed ID: 22889256
[TBL] [Abstract][Full Text] [Related]
67. Effect of fixed-dose hydrocortisone on vasopressor dose and mean arterial pressure in obese and nonobese patients with septic shock.
Lenney M; Kopp B; Erstad B
Am J Health Syst Pharm; 2022 Aug; 79(Suppl 3):S94-S99. PubMed ID: 35670445
[TBL] [Abstract][Full Text] [Related]
68. Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock.
Russell JA; Fjell C; Hsu JL; Lee T; Boyd J; Thair S; Singer J; Patterson AJ; Walley KR
Am J Respir Crit Care Med; 2013 Aug; 188(3):356-64. PubMed ID: 23796235
[TBL] [Abstract][Full Text] [Related]
69. Associations between peripheral perfusion disorders, mean arterial pressure and dose of norepinephrine administrated in the early phase of septic shock.
Magnin M; Amson H; Vacheron CH; Thiollière F; Piriou V; Junot S; Bonnet Garin JM; Allaouchiche B
Clin Exp Pharmacol Physiol; 2021 Oct; 48(10):1327-1335. PubMed ID: 34133795
[TBL] [Abstract][Full Text] [Related]
70. Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS).
Jeon K; Song JU; Chung CR; Yang JH; Suh GY
Crit Care; 2018 May; 22(1):131. PubMed ID: 29784057
[TBL] [Abstract][Full Text] [Related]
71. Dear vasopressin, where is your place in septic shock?
Duenser MW; Hasibeder WR
Crit Care; 2005 Apr; 9(2):134-5. PubMed ID: 15774061
[TBL] [Abstract][Full Text] [Related]
72. Vasopressin Response and Clinical Trajectory in Septic Shock Patients.
Bauer SR; Sacha GL; Siuba MT; Wang L; Wang X; Scheraga RG; Vachharajani V
J Intensive Care Med; 2023 Mar; 38(3):273-279. PubMed ID: 36062611
[TBL] [Abstract][Full Text] [Related]
73. The REPERFUSE study protocol: The effects of vasopressor therapy on renal perfusion in patients with septic shock-A mechanistically focused randomised control trial.
McDonald R; Watchorn J; Mehta R; Ostermann M; Hutchings S
PLoS One; 2024; 19(6):e0304227. PubMed ID: 38870103
[TBL] [Abstract][Full Text] [Related]
74. Microcirculation improvement after short-term infusion of vasopressin in septic shock is dependent on noradrenaline.
Nascente APM; Freitas FGR; Bakker J; Bafi AT; Ladeira RT; Azevedo LCP; Lima A; Machado FR
Clinics (Sao Paulo); 2017 Dec; 72(12):750-757. PubMed ID: 29319721
[TBL] [Abstract][Full Text] [Related]
75. The impact of endocrine supplementation on adverse events in septic shock.
Bissell BD; Erdman MJ; Smotherman C; Kraemer DF; Ferreira JA
J Crit Care; 2015 Dec; 30(6):1169-73. PubMed ID: 26404956
[TBL] [Abstract][Full Text] [Related]
76. Role of vasopressin in the management of septic shock.
Mutlu GM; Factor P
Intensive Care Med; 2004 Jul; 30(7):1276-91. PubMed ID: 15103461
[TBL] [Abstract][Full Text] [Related]
77. Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: a matched cohort study of the effect on survival.
Sawa N; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hoshino J; Suwabe T; Uchida N; Wake A; Taniguchi S; Takaichi K
Clin Nephrol; 2013 Jun; 79(6):463-70. PubMed ID: 23253903
[TBL] [Abstract][Full Text] [Related]
78. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock.
van Haren FM; Rozendaal FW; van der Hoeven JG
Chest; 2003 Dec; 124(6):2256-60. PubMed ID: 14665508
[TBL] [Abstract][Full Text] [Related]
79. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
[TBL] [Abstract][Full Text] [Related]
80. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
Colon Hidalgo D; Patel J; Masic D; Park D; Rech MA
J Crit Care; 2020 Feb; 55():145-148. PubMed ID: 31731173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
